Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation. (Q50860323)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

atrial fibrillation

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

William Maddox

1

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

G Neal Kay

2

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Takumi Yamada

3

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Jose Osorio

4

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Harish Doppalapudi

5

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Vance J Plumb

6

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Alicia Gunter

7

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

H Thomas McElderry

8

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

publication date

11 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Journal of Cardiovascular Electrophysiology

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

24

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

8

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

861-865

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio.

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

New anticoagulants for prevention of stroke in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

The use of dabigatran immediately after atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Personnel, Policy, Procedures and Follow-Up: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablatio

1 reference

https://api.crossref.org/works/10.1111%2FJCE.12143

21 January 2018

Identifiers

10.1111/JCE.12143

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 March 2018

http://europepmc.org/abstract/MED/23577951

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50860323&oldid=1580066635"